NPR

Teplizumab on Word of Mouth

Great personal news: my piece in Popular Science about anti-CD3 monoclonal antibodies (currently best known as teplizuma…

Copyright © 2009-2021 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.